Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents

Future Med Chem. 2019 Jan;11(2):83-95. doi: 10.4155/fmc-2018-0291. Epub 2019 Jan 15.

Abstract

Aim: Identification of new antiproliferative compounds.

Methodology: Four series of compounds were synthesized by the Mitsunobu reaction. Their antiproliferative activity was studied against several cancer cells and a noncancerous fibroblast cell line. Their apoptotic activity was analyzed using a caspase 3/7 fluorescence assay.

Results & conclusion: 9-alkylated-6-halogenated and 2,6-dihalogenated purines show remarkable inhibition of tumor cell proliferation, with the dichloro derivatives being the most potent of all the series. The most promising compound, tetrahydroquinoline 4c, exhibits significant antiproliferative activity against the cancer cells tested, while displaying a 19-fold lower potency against noncancerous fibroblasts, a key feature that indicates potential selectivity against cancer cells. This compound produces a high percentage of apoptosis (58%) after 24 h treatment in human breast cancer MCF-7 cells.

Keywords: Mitsunobu; antiproliferative activity; apoptosis; benzoxazine; pyridoxazine; quinoline.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Breast Neoplasms / drug therapy
  • Cell Proliferation / drug effects
  • Colonic Neoplasms / drug therapy
  • Drug Screening Assays, Antitumor
  • Female
  • HCT116 Cells
  • Halogenation
  • Humans
  • MCF-7 Cells
  • Purines / chemical synthesis
  • Purines / chemistry*
  • Purines / pharmacology*
  • Quinolines / chemical synthesis
  • Quinolines / chemistry*
  • Quinolines / pharmacology*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Purines
  • Quinolines
  • 1,2,3,4-tetrahydroquinoline